Sign in

Yale Cancer Center

@yalecancer.bsky.social
750 followers 154 following 1.1K posts

Yale Cancer Center is a collaboration between renowned cancer researchers and physicians at Yale University and Smilow Cancer Hospital.

PostsRepliesMedia
Yale Cancer Center @yalecancer.bsky.social · 12h
Register today to attend the Ella T. Grasso Memorial Conference in Gynecologic Oncology: 🗓️Wednesday, November 11 📍Yale West Campus, West Haven ⏰8am-2:30pm 🎤Keynote: Dr. Ursula Matulonis @danafarber.bsky.social ➡️For more info and to RSVP: bit.ly/4hNCJOV
000
Yale Cancer Center @yalecancer.bsky.social · 06/10/2026
Congratulations to Dr. Daniel Boffa, named Chair of the American College of Surgeons #ACS Commission on Cancer (CoC). Among his priorities as chair is helping hospital teams deliver high-quality #cancer care amid financial and workforce challenges. facs.org/media-center...
000
Yale Cancer Center @yalecancer.bsky.social · 06/10/2026
We are excited to welcome Dr. David Cescon for our #GrandRounds and Kingsbury Lecture in Breast Cancer presenting "All You Need is Blood? ctDNA in Breast Cancer: Building Evidence Toward Personalized Care." Join us in Smilow Auditorium or via Zoom, today at 12pm: bit.ly/4rDRDLW
000
Yale Cancer Center @yalecancer.bsky.social · 05/10/2026
Celebrating a powerful day at our annual Metastatic Breast Cancer Conference. We were honored to welcome so many patients, caregivers, researchers, and physicians together for a day of connection, education, and hope. 🩷 @maryamlustberg.bsky.social @adrianakahn.bsky.social
010
Yale Cancer Center @yalecancer.bsky.social · 04/10/2026
Dr. Kathleen Suozzi talks with Dr. Eric Winer tonight at 7:30pm on #YaleCancerAnswers. They review differences between #basalcell and #squamouscell carcinomas, and how everyone can protect their skin and still enjoy the outdoors. 🎧Listen live #WNPR 💻Listen later #ApplePodcasts, #Spotify, #YouTube
000
Yale Cancer Center @yalecancer.bsky.social · 02/10/2026
With shortages of the #HPV vaccine, Dr. Daniel DiMaio @yalegenetics.bsky.social and his lab developed a genetic platform to cultivate HPV and identify viral variants, establishing the first system to use genetic selection for HPV. medicine.yale.edu/cancer/news-... @oncoalert.bsky.social
medicine.yale.edu
Cultivating HPV to Improve Vaccine Development
Researchers developed a platform to help overcome the manufacturing challenges—and shortages—of the HPV vaccine.
000
Yale Cancer Center @yalecancer.bsky.social · 01/10/2026
A revolutionary #cancer treatment that extracts a patient’s own immune cells, and re-engineers them to recognize tumor targets, CAR-T therapy, is now being studied at Yale for autoimmune diseases including lupus, multiple sclerosis, and scleroderma. medicine.yale.edu/cancer/news-...
medicine.yale.edu
Enhancing CAR-T Therapy: From Cancer to Autoimmune Diseases
Yale researchers are testing CAR-T therapy in clinical trials for autoimmune diseases including lupus, multiple sclerosis, and scleroderma. They're also working
021
Yale Cancer Center @yalecancer.bsky.social · 30/09/2026
Beatrice Katsnelson shared analysis of 2,186 patients with #NSCLC, noting KEAP1 & SMARCA4 tumor mutations predicted development of bone mets. Findings suggest molecular profiling could identify high-risk pts and increase surveillance strategies. #ASTRO26 @astro-org.bsky.social @oncoalert.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 30/09/2026
Dr. Victor Lee shared that patients with #prostatecancer & TP53 mutations had higher pathologic lymph node involvement. Noting incorporating TP53 mutational status into risk stratification models could improve patient selection for elective nodal irradiation. #ASTRO26 @oncoalert.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 30/09/2026
Dr. Mary-Kate Lawlor presented new data #ASTRO26 showing in 81 patients with stage III uterine serous carcinoma, #EBRT significantly improved pelvic control + OS vs vaginal brachytherapy alone (4-year OS 87% vs. 55%) without increased toxicity. @astro-org.bsky.social @oncoalert.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 30/09/2026
Dr. Victor Lee presents an analysis of patients with stage I–III #breastcancer through MSK-CHORD #ASTRO26 showing TP53 mutations were associated with development of brain mets, suggesting TP53 mutational status may enhance risk stratification. @astro-org.bsky.social @oncoalert.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 30/09/2026
Congratulations to Dr. Christopher Rodman, recipient of @nanets.bsky.social Clinical Investigator Scholarship (NCIS) Award for: "Radiomics, Deep Learning, and Digital Pathology to Identify Biomarkers of Response & Resistance to Capecitabine/Temozolomide in Advanced Pancreatic Neuroendocrine Tumors.”
010
Yale Cancer Center @yalecancer.bsky.social · 30/09/2026
Dr. Mary Kate Lawlor presented a Quick Pitch presentation earlier today at #ASTRO26 on "Morbidity of Pelvic Recurrence in Stage 3 Uterine Serous Carcinoma." amportal.astro.org/sessions/qp-29… @astro-org.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 29/09/2026
Dr. Victor Lee will present during a Scientific Symposium this afternoon #ASTRO26 on "TP53 Mutations in Primary Breast Tumors Predict Brain Metastases: Insights from the MSK CHORD Cohort." amportal.astro.org/sessions/ss-40… @astro-org.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 29/09/2026
Dr. Ignaty Leshchiner and colleagues analyzed #cfDNA blood samples from 12,000+ patients with metastatic #breastcancer & found serial cfDNA testing can detect newly-emerging resistance mutations before clinical progression. medicine.yale.edu/cancer/publi... @yalecbb.bsky.social
medicine.yale.edu
Blood-Based Circulating DNA Testing Maps Metastatic Breast Cancer
This study shows that liquid biopsy—blood-based tumor DNA testing—reveals widespread treatment-resistance mutations across 12,827 patients with metastatic
000
Yale Cancer Center @yalecancer.bsky.social · 29/09/2026
Stop by Exhibit Hall A this afternoon #ASTRO26 as we have five poster presentations on the schedule, featuring: Yue Tang; Daniel Liu; Beatrice Katsnelson; and Victor Lee. @yaleschoolofmed.bsky.social @astro-org.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 29/09/2026
New data from Dr. Erica Shen #ASTRO2026 finds in adults undergoing allogeneic stem cell transplant for ALL or AML, TBI with lung shielding yielded a 13.4% rate of severe pulmonary toxicity. @astro-org.bsky.social @oncoalert.bsky.social
020
Yale Cancer Center @yalecancer.bsky.social · 29/09/2026
Dr. James Ninia presents the HyDEF phase I trial #ASTRO26. The protocol treats two halves of the same tumor with radiobiologically equivalent but different fractionated doses. @astro-org.bsky.social @oncoalert.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 29/09/2026
Proud to have Drs. Henry Park; Shari Damast; Melissa Young; and Suzanne Evans moderating education sessions during Monday's program at #ASTRO2026, representing the depth of expertise and academic leadership in our department. Thank you and congratulations to all four! @astro-org.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 29/09/2026
New data presented by Maneeth Ellendula @yaleschoolofmed.bsky.social #ASTRO2026 identifies SMARCA4 mutations as a predictor of brain mets in early-stage non-small lung cancer #NSCLC. @astro-org.bsky.social @oncoalert.bsky.social
001
Yale Cancer Center @yalecancer.bsky.social · 29/09/2026
Maneeth Ellendula @yaleschoolofmed.bsky.social presented a Quick Pitch presentation today #ASTRO26: "Association of SMARCA4 Primary Tumor Mutations with Brain Metastases in Initially Non-Metastatic Non-Small Cell Lung Cancer." amportal.astro.org/sessions/qp-12… @astro-org.bsky.social
010
Yale Cancer Center @yalecancer.bsky.social · 28/09/2026
This afternoon in Room 256, Dr. Suzanne Evans presents "Safety and Quality Considerations in Clinical Care: Lessons Learned from RO-ILS" as part of an #ASTRO26 Education Session.amportal.astro.org/sessions/edu-2… @astro-org.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 28/09/2026
At #ASTRO26, we are proud to welcome so many Yale attendees, including our current residents and the alumni of our Radiation Oncology Residency Program, and advancing the field of radiation oncology. @astro-org.bsky.social @oncoalert.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 28/09/2026
At #ASTRO26 Dr. Cary Gross @carygross.bsky.social presented on Comparative Effectiveness and Value in Cancer Care, exploring how we measure and communicate the value of #radiationoncology and #cancercare. @astro-org.bsky.social @oncoalert.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 28/09/2026
Dr. Shari Damast presented "Advanced #EndometrialCancer Case Discussion - The Significance of Molecular Status" in an #ASTRO26 Education Session this morning. amportal.astro.org/sessions/edu-2… @astro-org.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 28/09/2026
Today at #ASTRO26, we have two AM and two PM poster presentations scheduled in Exhibit Hall A. Please stop by and support your colleagues and their research: Drs. Dae Han; Anvi Sud; James Ninia; and Erica Shen. @astro-org.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 28/09/2026
De. Henry Park at #ASTRO26: How should we interpret randomized Phase II trials in radiation oncology? Dr. Park reviewed the potential impact of phase II clinical trials, while reviewing the need for scrutiny of results. @astro-org.bsky.social @oncoalert.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 28/09/2026
Dr. James Ninia shares a case series of early radium therapy from the #YNHH archives, the birth of modern #brachytherapy, at #ASTRO26. @astro-org.bsky.social @oncoalert.bsky.social amportal.astro.org/sessions/pqa-0…
000
Yale Cancer Center @yalecancer.bsky.social · 28/09/2026
Dr. Shari Bodofsky shares research #ASTRO26 showing women <45 with rectal cancer who undergo pelvic radiation face early menopause. Early counseling on fertility preservation and hormone therapy improve outcomes. @astro-org.bsky.social @oncoalert.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 28/09/2026
This morning in Room 256 at #ASTRO26, @carygross.bsky.social presents "Comparative Effectiveness and Value in Cancer Care" as part of an Education Session. amportal.astro.org/sessions/edu-1… @astro-org.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 27/09/2026
New research from Dr. Giorgio Caturegli at #ASTRO26 compares neoadjuvant FOLFOX vs. CROSS chemoradiation for esophageal adenocarcinoma. FOLFOX was associated with higher CRR, higher 5-year recurrence-free and overall survival in unadjusted analyses. @astro-org.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 27/09/2026
Today at 4:45pm in Rm 210 #ASTRO26, Dr. Henry Park presents "Promising or Premature? Making Sense of Randomized Phase 2 Trials in #RadiationOncology." ➡️amportal.astro.org/sessions/pro-1… @astro-org.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 27/09/2026
As #ASTRO26 begins, we start with six poster presentations today at 3pm featuring Drs. Shari Bodofsky; Giorgio Caturgli; Alexis Gayne; Ella Zhang; James Ninia; and Colin McNamara. @ASTRO_org
010
Yale Cancer Center @yalecancer.bsky.social · 27/09/2026
Tonight at 7:30pm on #YaleCancerAnswers, Dr. Jeremy Kortmansky shares insight into the changes in the management of GI cancers and the impact of #immunotherapy and combination therapies. 🎧Listen live #wnpr 💻Listen later #ApplePodcasts; #Spotify; #YouTube
020
Yale Cancer Center @yalecancer.bsky.social · 25/09/2026
Thank you, @anirbanmaitra.bsky.social for your excellent presentation and visit to New Haven! Watch Dr. Maitra's full talk, "Mediators of Restraint in Early Pancreatic Neoplasia," on our YouTube channel: youtu.be/j_VYvB0R3_Y?.... @pamelakunzmd.bsky.social
youtu.be
Mediators of Restraint in Early Pancreatic Neoplasia with Dr. Anirban Maitra
YouTube video by Yale Cancer Center
010
Yale Cancer Center @yalecancer.bsky.social · 23/09/2026
Smilow Cancer Hospital’s Cellular Therapy Program is proud to announce that it ranks 3rd in the nation in patients treated with #Breyanzi. We’re proud of this achievement and remain committed to providing exceptional care to patients. @yale-hematology.bsky.social @cibmtr.bsky.social
000
Yale Cancer Center @yalecancer.bsky.social · 22/09/2026
Today at 12pm, we are pleased to welcome Dr. Anirban Maitra @anirbanmaitra.bsky.social for our #GrandRounds and Koenigsberg Lecture! Dr. Maitra will present "Mediators of Restraint in Early Pancreatic Neoplasia." Join us in Smilow Auditorium or online via Zoom: bit.ly/4gWZv7G.
000
Yale Cancer Center @yalecancer.bsky.social · 22/09/2026
Dr. Cece Calhoun joined the #HemeTalks #Podcast to discuss one of the most vulnerable moments in #sicklecell care: the transition from pediatric to adult management. open.spotify.com/episode/53Be... @yale-hematology.bsky.social @ash.hematology.org
030
Yale Cancer Center @yalecancer.bsky.social · 21/09/2026
We’re grateful for the @yale.edu College Class of 1961 #CancerEndowment, which has grown to more than $3.5 million, awarding over $900,000 in research grants to young scientists at @yalecancer.bsky.social. medicine.yale.edu/news-article...
000
Yale Cancer Center @yalecancer.bsky.social · 21/09/2026
Yesterday’s #SmilowSalute was an emotional and exciting stop on @ctfride.bsky.social 💙 A huge thank you to our amazing riders, volunteers, and donors for your enthusiasm and support of patient care and research at Smilow Cancer Hospital and Yale Cancer Center. #CTFRide
010
Yale Cancer Center @yalecancer.bsky.social · 18/09/2026
#Osimertinib appears to ⬇️ the elevated brain metastasis risk historically associated with two common subtypes of EGFR mutations, supporting osimertinib's role as a preferred first-line treatment for EGFR-mutant #NSCLC. medicine.yale.edu/cancer/publi... @oncoalert.bsky.social
medicine.yale.edu
Osimertinib and Brain Metastasis Risk in Lung Cancer
This study shows that osimertinib reduces brain metastasis risk differences seen between two common EGFR lung cancer mutation subtypes.
012
Yale Cancer Center @yalecancer.bsky.social · 16/09/2026
Congratulations Dr. Jeremy Jacox, recipient of a Seed Grant from the Hirshberg Foundation. The grant program provides early funding to support basic scientists and clinicians for improving diagnosis and developing new treatment modalities for #pancreaticcancer. pancreatic.org/research/see...
011
Yale Cancer Center @yalecancer.bsky.social · 16/09/2026
Elaine Yang @yaleschoolofmed.bsky.social presented research during a poster session yesterday at #WCLC in Seoul: "CT-Detected Residual Thymic Tissue Predicts Pathologic Complete Response to Neoadjuvant Therapy in Locally Advanced #NSCLC." cattendee.abstractsonline.com/meeting/2148...
010
Yale Cancer Center @yalecancer.bsky.social · 16/09/2026
Dr. VIctor Lee presented a mini-oral session yesterday at #WCLC in Seoul: "ATRX Mutations Are Enriched in Female #NSCLC and Associated With Higher Tumor Mutational Burden." cattendee.abstractsonline.com/meeting/2148... @iaslc.bsky.social
010
Yale Cancer Center @yalecancer.bsky.social · 15/09/2026
Today at 12pm marks the return of our #GrandRounds! Drs. Maximilian Stahl and Jan Bewersdorf present on "New Directions in #AML and #Myelofibrosis." Join us in Smilow Auditorium or online via Zoom: bit.ly/4A7szkr @yale-hematology.bsky.social
010
Yale Cancer Center @yalecancer.bsky.social · 15/09/2026
Dr. Patrick Oh presented his research during a poster session yesterday at #WCLC in Seoul: "Poor Survival and Increased Nodal Metastasis in SMARCA4-Mutant Lung Adenocarcinoma in a Multi-Cohort Analysis." cattendee.abstractsonline.com/meeting/2148... @iaslc.bsky.social
010
Yale Cancer Center @yalecancer.bsky.social · 15/09/2026
In new #pancreascancer research, @muzumdarlab.bsky.social et al. find that the pre-existing molecular state of a #PDAC cell exerts greater influence over how a #KRAS mutation behaves than the identity of the mutation itself. medicine.yale.edu/cancer/publi... @molecularomics.bsky.social
medicine.yale.edu
How Cell State Shapes KRAS Mutation Effects in Pancreatic Cancer
This study shows that in pancreatic cancer cells, a cell's baseline state—not which KRAS mutation it carries—drives its molecular behavior.
012
Yale Cancer Center @yalecancer.bsky.social · 14/09/2026
Dr. Henry Park, an accomplished violinist, returned to the stage at #WCLC to perform alongside Dr. Andreas Rimner at the Journal of Thoracic Oncology #JTO 20th Anniversary Reception! @iaslc.bsky.social @yale.edu
000
Yale Cancer Center @yalecancer.bsky.social · 14/09/2026
Dr. Anne Chiang presented at #WCLC in Seoul as a discussant for the exciting primary results of the Phase 3 ARTEMIS-008 trial, debated optimal use of therapeutic agents in #SCLC, and saw a friendly face! @iaslc.bsky.social
020
Yale Cancer Center @yalecancer.bsky.social · 14/09/2026
Dr. Henry Park presents a research poster at #WCLC in Seoul tonight on "Androgen Receptor Mutations in #NSCLC are Enriched in Females and Predict Better Immunotherapy Response." cattendee.abstractsonline.com/meeting/21487/… @iaslc.bsky.social
000